NEW YORK, Feb. 4 - Molecular Staging of New Haven, Conn., and the Scripps Research Institute have won an award totaling up to $2.5 million from the National Institute of Diabetes and Digestive and Kidney disease (NIDDK) to produce large samples of genomic DNA for genetic disease studies, the company said today.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.